13 December 2021 - The Scottish Medicines Consortium, which advises on newly licensed medicines for use by NHSScotland, has published advice accepting six new medicines.

Olaparib (Lynparza) was accepted for the treatment of ovarian cancer with certain genetic mutations.

Read SMC press release